| Prenetics’ IM8 Named Exclusive Health Supplements Partner of Inter Miami CF in Multi-Year Partnership |
Globe Newswire |
05/07 |
08:30 |
| Weatherford Awarded Managed Pressure Drilling Contract by Ventura Offshore for Operations in Brazil |
Globe Newswire |
05/07 |
08:30 |
| Dogwood Therapeutics to Report First Quarter 2026 Financial Results on Thursday, May 14, 2026 |
Globe Newswire |
05/07 |
08:30 |
| Quoin Pharmaceuticals Provides Corporate Update and Reports First Quarter 2026 Financial Results |
Globe Newswire |
05/07 |
08:30 |
| Devon Energy and Coterra Energy Complete Merger |
Globe Newswire |
05/07 |
08:30 |
| Cadrenal Therapeutics Reports First Quarter 2026 Financial Results and Provides Phase 3 Development Update on CAD-1005 Following End-of-Phase 2 Meeting with FDA |
Globe Newswire |
05/07 |
08:30 |
| EverQuote to Present at Upcoming Investor Conferences |
Globe Newswire |
05/07 |
08:30 |
| List of Social Casinos in USA Verified for New US Players by SweepsPulse |
Globe Newswire |
05/07 |
08:27 |
| AIM ImmunoTech Announces 50% Objective Response Rate (ORR) in UPMC Recurrent Ovarian Cancer Phase 2 Clinical Trial, Suggesting Breakthrough Combination Potential |
Globe Newswire |
05/07 |
08:23 |
| Inuvo to Host First Quarter 2026 Financial Results Conference Call on Thursday, May 14th at 4:15 P.M. ET |
Globe Newswire |
05/07 |
08:15 |
| NANO Nuclear to Hold Second Quarter Business Update Webcast on May 14, 2026 |
Globe Newswire |
05/07 |
08:06 |
| Alpha Modus and SurgePays Sign 25,000-Activation Pilot to Launch Alpha Cash Across SurgePays' Prepaid Wireless and Convenience-Store Distribution Network |
Globe Newswire |
05/07 |
08:05 |
| Silo Pharma Files Provisional Patent for Ibogaine-Based Therapeutic Targeting Traumatic Brain Injury |
Globe Newswire |
05/07 |
08:05 |
| Scienture Secures $11.0 Million in Non-Dilutive Debt Financing to Accelerate Growth of Approved Product Portfolio and Advancement of R&D Pipeline |
Globe Newswire |
05/07 |
08:05 |
| Ardelyx Presents Analysis Supporting Long-Term Safety of XPHOZAH at NKF’s Spring Clinical Meetings |
Globe Newswire |
05/07 |
08:01 |
| Chanson International Holding Advances Growth Strategy Through AI-Driven Intelligent Manufacturing and Industrial Upgrade |
Globe Newswire |
05/07 |
08:00 |
| MBX Biosciences Reports First Quarter 2026 Financial Results and Corporate Highlights |
Globe Newswire |
05/07 |
08:00 |
| Praxis Precision Medicines Provides Corporate Update and Reports First Quarter 2026 Financial Results |
Globe Newswire |
05/07 |
08:00 |
| Celcuity Schedules Release of First Quarter 2026 Financial Results and Webcast/Conference Call |
Globe Newswire |
05/07 |
08:00 |
| NRx Pharmaceuticals (Nasdaq:NRXP) Announces FDA Clearance to Proceed with Clinical Trial of NRX-101 in Combination with Robotic-enabled Transcranial Magnetic Stimulation in Patients with Depression and Suicidality |
Globe Newswire |
05/07 |
08:00 |
| DarkIris Inc. Announces 16 for 1 Share Consolidation |
Globe Newswire |
05/07 |
08:00 |
| Viasat Announces Appointment of Shekar Ayyar and Jinhy Yoon to Board of Directors and Enters into Cooperation Agreement with Carronade Capital Management |
Globe Newswire |
05/07 |
08:00 |
| MediWound to Report First Quarter 2026 Financial Results |
Globe Newswire |
05/07 |
08:00 |
| Diginex Deputy Chairman Discusses Strategic Reset, and Integrated AI‑Driven Platform Strategy in New Investor Interview |
Globe Newswire |
05/07 |
08:00 |
| ArriVent Announces IND Clearance for Novel Tetravalent MUC16/NaPi2b Targeting ADC ARR-002 with Initial Focus in Ovarian and Endometrial Cancers |
Globe Newswire |
05/07 |
08:00 |
